The 86-year-old female has the past higtory of 
1. Transverse colon adenocarcinoma, pT3N4aM1, status post left hemicolectomy on 2013/09/23, with lung and liver metastases, status post adjuvant chemotherapy with UFUR (2013/11/14~2014/02/11), and then Xeloda (2014/02/11~)
2. Ileus, malignancy related, improved
3. Malignant pleural effusion
4. Pericardial effusion
5. Thyroid poorly-defferentiated carcinoma, status post right thyroidectomy on 2013/04/29, under Eltroxin 100 mcg QW1,2,4,5,7
6. HBV carrier under Baraclude 0.5 mg 1# QD.
Before this admission, she received oral chemotherapy of Xeloda at outpatient clinic and she just discharged from 9A due to malignancy related ileus on 2015/07/09.

Active problems:
1. OHCA, ROSC after CPR, suspect uroseptic shock related, status post endotracheal tube insertion with mechanical ventilation (2015/08/17~), under hypothermia thewrapy (2015/08/17~)
2. Transverse colon adenocarcinoma, pT3N4aM1, status post left hemicolectomy on 2013/09/23, with lung and liver metastases, status post adjuvant chemotherapy with UFUR (2013/11/14~2014/02/11), and then Xeloda (2014/02/11~), with 
malignant pleural effusion

OHCA at bed, asystole, s/p CPCR for 13 +16 min, ROSC.
No choking hx.
CxR and Chest CT showed bil metastasis, Rt pleural effusion, pericardial effusion, and liver large metastasis.
BIS 89, no clinical obvious seizure.
Brain stem reflex all negative.

S/P therapeutic hypothermia.

EEG: suspect isoelectricity.
Desaturation this morning
EEG: no acttivity
CXR: bilateral infiltration 
2015/08/28 16:55 GCS:E1M1VT
2015/08/28 16:32 SpO2:98%(35%,L,VCR)
2015/08/28 16:32 BP:81/49
Family meeting today: her son and daughter and son-in-law agree active withdraw of life support system

Mx: 
1. combine hospice team for cancer terminal care.
2. family: withdraw

86F
1. Out of hospital cardiac arrest, suspect uroseptic shock related, status post endotracheal tube insertion with mechanical ventilation (2015/08/17~), under hypothermia thewrapy (2015/08/17~)
2. Uroseptic shock 
3. Transverse colon adenocarcinoma, pT3N4aM1, status post left hemicolectomy on 2013/09/23, with lung and liver metastases, status post adjuvant chemotherapy with UFUR (2013/11/14~2014/02/11), and then Xeloda (2014/02/11~)
4. Ileus, malignancy related, improved
5. Malignant pleural effusion
6. Pericardial effusion
7. Thyroid poorly-defferentiated carcinoma, status post right thyroidectomy on 2013/04/29, under Eltroxin 100 mcg QW1,2,4,5,7
8. HBV carrier under Baraclude 0.5 mg 1# QD

DNR(+) and family agree withdraw.

Extubation was performed smoothly at 14:45pm.